BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maring JA, Lodder K, Mol E, Verhage V, Wiesmeijer KC, Dingenouts CKE, Moerkamp AT, Deddens JC, Vader P, Smits AM, Sluijter JPG, Goumans MJ. Cardiac Progenitor Cell-Derived Extracellular Vesicles Reduce Infarct Size and Associate with Increased Cardiovascular Cell Proliferation. J Cardiovasc Transl Res 2019;12:5-17. [PMID: 30456736 DOI: 10.1007/s12265-018-9842-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Herrera-zelada N, Zúñiga-cuevas Ú, Ramírez-reyes A, Norambuena-soto I, Venegas-zamora L, Troncoso MF, Hernández A, Sánchez G, Pedrozo Z, Lavandero S, Riquelme JA. Endothelial activation impairs the function of small extracellular vesicles. Front Pharmacol 2023;14. [DOI: 10.3389/fphar.2023.1143888] [Reference Citation Analysis]
2 Karnas E, Dudek P, Zuba-Surma EK. Stem cell- derived extracellular vesicles as new tools in regenerative medicine - Immunomodulatory role and future perspectives. Front Immunol 2023;14:1120175. [PMID: 36761725 DOI: 10.3389/fimmu.2023.1120175] [Reference Citation Analysis]
3 Okamura A, Yoshioka Y, Saito Y, Ochiya T. Can Extracellular Vesicles as Drug Delivery Systems Be a Game Changer in Cardiac Disease? Pharm Res 2022. [PMID: 36577860 DOI: 10.1007/s11095-022-03463-z] [Reference Citation Analysis]
4 Roefs MT, Heusermann W, Brans MAD, Snijders Blok C, Lei Z, Vader P, Sluijter JPG. Evaluation and manipulation of tissue and cellular distribution of cardiac progenitor cell-derived extracellular vesicles. Front Pharmacol 2022;13:1052091. [PMID: 36506565 DOI: 10.3389/fphar.2022.1052091] [Reference Citation Analysis]
5 Zhaoer Y, Mingming G, Wei Z, Dan Y, Yating Q, Ruizhe J. Extracellular vesicles for the treatment of preeclampsia. Tissue and Cell 2022;77:101860. [DOI: 10.1016/j.tice.2022.101860] [Reference Citation Analysis]
6 Bogdan Severus G, Ruxandra Florentina I, Robert Mihai E, Elena Codruța D, Sanda Maria C, Dragoș C, Silviu Cristian V. Extracellular Vesicles as Intercellular Communication Vehicles in Regenerative Medicine. Extracellular Vesicles - Role in Diseases, Pathogenesis and Therapy 2022. [DOI: 10.5772/intechopen.101530] [Reference Citation Analysis]
7 Li X, Wang X, He P, Bennett E, Haggard E, Ma J, Cai C. Mitochondrial Membrane Potential Identifies a Subpopulation of Mesenchymal Progenitor Cells to Promote Angiogenesis and Myocardial Repair. Cells 2022;11:1713. [DOI: 10.3390/cells11101713] [Reference Citation Analysis]
8 Dehkordi NR, Dehkordi NR, Farjoo MH. Therapeutic properties of stem cell-derived exosomes in ischemic heart disease. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174839] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Haider KH, Najimi M. Exosome-Based Cell-Free Therapy in Regenerative Medicine for Myocardial Repair. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-19-2655-6_42] [Reference Citation Analysis]
10 Haider KH, Najimi M. Exosome-Based Cell-Free Therapy in Regenerative Medicine for Myocardial Repair. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-16-6016-0_42-1] [Reference Citation Analysis]
11 Marson D, Aulic S, Fermeglia A, Laurini E, Pricl S. Nanovesicles for the delivery of cardiovascular drugs. Applications of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91865-7.00009-2] [Reference Citation Analysis]
12 Jadli AS, Parasor A, Gomes KP, Shandilya R, Patel VB. Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger. Front Cardiovasc Med 2021;8:767488. [PMID: 34869682 DOI: 10.3389/fcvm.2021.767488] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
13 van de Wakker SI, van Oudheusden J, Mol EA, Roefs MT, Zheng W, Görgens A, El Andaloussi S, Sluijter JPG, Vader P. Influence of short term storage conditions, concentration methodsand excipients on extracellular vesicle recovery and function. Eur J Pharm Biopharm 2021:S0939-6411(21)00343-X. [PMID: 34864197 DOI: 10.1016/j.ejpb.2021.11.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
14 Lodrini AM, Goumans MJ. Cardiomyocytes Cellular Phenotypes After Myocardial Infarction. Front Cardiovasc Med 2021;8:750510. [PMID: 34820429 DOI: 10.3389/fcvm.2021.750510] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
15 Salybekov AA, Salybekova A, Sheng Y, Shinozaki Y, Yokoyama K, Kobayashi S, Asahara T. Extracellular Vesicles Derived From Regeneration Associated Cells Preserve Heart Function After Ischemia-Induced Injury. Front Cardiovasc Med 2021;8:754254. [PMID: 34746267 DOI: 10.3389/fcvm.2021.754254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Coffey S, Dixit P, Saw EL, Babakr AA, van Hout I, Galvin IF, Saxena P, Bunton RW, Davis PJ, Lamberts RR, Katare R, Williams MJA. Thiamine increases resident endoglin positive cardiac progenitor cells and atrial contractile force in humans: A randomised controlled trial. Int J Cardiol 2021;341:70-3. [PMID: 34461161 DOI: 10.1016/j.ijcard.2021.08.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wang H, Maimaitiaili R, Yao J, Xie Y, Qiang S, Hu F, Li X, Shi C, Jia P, Yang H, Wei M, Zhao J, Zhou Z, Xie J, Jiang J, Cai H, Sluijter JPG, Xu Y, Zhang Y, Xiao J. Percutaneous Intracoronary Delivery of Plasma Extracellular Vesicles Protects the Myocardium Against Ischemia-Reperfusion Injury in Canis. Hypertension 2021;78:1541-54. [PMID: 34488435 DOI: 10.1161/HYPERTENSIONAHA.121.17574] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
18 Shouman S, Zaher A, Abdelhameed A, Elshaboury S, Sakr S, Fouda BE, Mohamed H, El-Badri N. Cardiac Progenitor Cells. Adv Exp Med Biol 2021;1312:51-73. [PMID: 33159305 DOI: 10.1007/5584_2020_594] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Ghafouri-Fard S, Niazi V, Hussen BM, Omrani MD, Taheri M, Basiri A. The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes. Front Cell Dev Biol 2021;9:653296. [PMID: 34307345 DOI: 10.3389/fcell.2021.653296] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
20 Garbayo E, Ruiz-Villalba A, Hernandez SC, Saludas L, Abizanda G, Pelacho B, Roncal C, Sanchez B, Palacios I, Prósper F, Blanco-Prieto MJ. Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction. Acta Biomater 2021;126:394-407. [PMID: 33716175 DOI: 10.1016/j.actbio.2021.03.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Saludas L, Oliveira CC, Roncal C, Ruiz-Villalba A, Prósper F, Garbayo E, Blanco-Prieto MJ. Extracellular Vesicle-Based Therapeutics for Heart Repair. Nanomaterials (Basel) 2021;11:570. [PMID: 33668836 DOI: 10.3390/nano11030570] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
22 Nguyen BY, Azam T, Wang X. Cellular signaling cross-talk between different cardiac cell populations: an insight into the role of exosomes in the heart diseases and therapy. Am J Physiol Heart Circ Physiol 2021;320:H1213-34. [PMID: 33513083 DOI: 10.1152/ajpheart.00718.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
23 Porzionato A, Zaramella P, Dedja A, Guidolin D, Bonadies L, Macchi V, Pozzobon M, Jurga M, Perilongo G, De Caro R, Baraldi E, Muraca M. Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2021;320:L688-704. [PMID: 33502939 DOI: 10.1152/ajplung.00148.2020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
24 Pan S, Jeevanandam J, Acquah C, Tan KX, Udenigwe CC, Danquah MK. Drug delivery systems for cardiovascular ailments. Drug Delivery Devices and Therapeutic Systems 2021. [DOI: 10.1016/b978-0-12-819838-4.00019-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Kulkarni P, Rawtani D, Kumar M, Lahoti SR. Cardiovascular drug delivery: A review on the recent advancements in nanocarrier based drug delivery with a brief emphasis on the novel use of magnetoliposomes and extracellular vesicles and ongoing clinical trial research. Journal of Drug Delivery Science and Technology 2020;60:102029. [DOI: 10.1016/j.jddst.2020.102029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
26 Schava SP, Stepanov EV, Sorokin VA. The exosomes role in pathogenesis of cardiovascular diseases. Transl med (Print) 2020;7:17-28. [DOI: 10.18705/2311-4495-2020-7-5-17-28] [Reference Citation Analysis]
27 Charles CJ, Li RR, Yeung T, Mazlan SMI, Lai RC, de Kleijn DPV, Lim SK, Richards AM. Systemic Mesenchymal Stem Cell-Derived Exosomes Reduce Myocardial Infarct Size: Characterization With MRI in a Porcine Model. Front Cardiovasc Med 2020;7:601990. [PMID: 33304934 DOI: 10.3389/fcvm.2020.601990] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
28 Martins-Marques T, Hausenloy DJ, Sluijter JPG, Leybaert L, Girao H. Intercellular Communication in the Heart: Therapeutic Opportunities for Cardiac Ischemia. Trends Mol Med 2021;27:248-62. [PMID: 33139169 DOI: 10.1016/j.molmed.2020.10.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
29 Huang C, Neupane YR, Lim XC, Shekhani R, Czarny B, Wacker MG, Pastorin G, Wang JW. Extracellular vesicles in cardiovascular disease. Adv Clin Chem 2021;103:47-95. [PMID: 34229852 DOI: 10.1016/bs.acc.2020.08.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
30 Mancuso T, Barone A, Salatino A, Molinaro C, Marino F, Scalise M, Torella M, De Angelis A, Urbanek K, Torella D, Cianflone E. Unravelling the Biology of Adult Cardiac Stem Cell-Derived Exosomes to Foster Endogenous Cardiac Regeneration and Repair. Int J Mol Sci 2020;21:E3725. [PMID: 32466282 DOI: 10.3390/ijms21103725] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
31 Nazari-Shafti TZ, Exarchos V, Biefer HRC, Cesarovic N, Meyborg H, Falk V, Emmert MY. MicroRNA Mediated Cardioprotection - Is There a Path to Clinical Translation? Front Bioeng Biotechnol 2020;8:149. [PMID: 32266222 DOI: 10.3389/fbioe.2020.00149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
32 Balbi C, Costa A, Barile L, Bollini S. Message in a Bottle: Upgrading Cardiac Repair into Rejuvenation. Cells 2020;9:E724. [PMID: 32183455 DOI: 10.3390/cells9030724] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
33 Mol EA, Lei Z, Roefs MT, Bakker MH, Goumans MJ, Doevendans PA, Dankers PYW, Vader P, Sluijter JPG. Injectable Supramolecular Ureidopyrimidinone Hydrogels Provide Sustained Release of Extracellular Vesicle Therapeutics. Adv Healthc Mater 2019;8:e1900847. [PMID: 31559704 DOI: 10.1002/adhm.201900847] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 8.5] [Reference Citation Analysis]
34 Waters R, Subham S, Pacelli S, Modaresi S, Chakravarti AR, Paul A. Development of MicroRNA-146a-Enriched Stem Cell Secretome for Wound-Healing Applications. Mol Pharm 2019;16:4302-12. [PMID: 31398053 DOI: 10.1021/acs.molpharmaceut.9b00639] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
35 de Jong OG, Kooijmans SAA, Murphy DE, Jiang L, Evers MJW, Sluijter JPG, Vader P, Schiffelers RM. Drug Delivery with Extracellular Vesicles: From Imagination to Innovation. Acc Chem Res 2019;52:1761-70. [PMID: 31181910 DOI: 10.1021/acs.accounts.9b00109] [Cited by in Crossref: 131] [Cited by in F6Publishing: 140] [Article Influence: 32.8] [Reference Citation Analysis]
36 Chong SY, Lee CK, Huang C, Ou YH, Charles CJ, Richards AM, Neupane YR, Pavon MV, Zharkova O, Pastorin G, Wang JW. Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers. Int J Mol Sci 2019;20:E3272. [PMID: 31277271 DOI: 10.3390/ijms20133272] [Cited by in Crossref: 54] [Cited by in F6Publishing: 62] [Article Influence: 13.5] [Reference Citation Analysis]
37 Xu MY, Ye ZS, Song XT, Huang RC. Differences in the cargos and functions of exosomes derived from six cardiac cell types: a systematic review. Stem Cell Res Ther 2019;10:194. [PMID: 31248454 DOI: 10.1186/s13287-019-1297-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 9.5] [Reference Citation Analysis]
38 Wang J, Zhao C, Xiao J. Exosomes in Cardiovascular Diseases and Treatment: Experimental and Clinical Aspects. J of Cardiovasc Trans Res 2019;12:1-2. [DOI: 10.1007/s12265-018-9860-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Zhang Z, Duan Y, Bei Y. Cardiac Progenitor Cell-Derived Extracellular Vesicles: a Rising Star for Cardiac Repair and Regeneration. J of Cardiovasc Trans Res 2019;12:3-4. [DOI: 10.1007/s12265-018-9862-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]